<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>DVT and PE • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="DVT and PE • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/DVT and PE/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/DVT and PE/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="dvt-and-pe" tabindex="-1">DVT and PE</h1>
<ul>
<li>related: <a href="/wiki/notes/Hemeonc/">Hemeonc</a></li>
<li>tags: #hemeonc</li>
</ul>
<hr>
<p>It is unusual for an otherwise healthy 37-year-old to suddenly develop a DVT, especially in the absence of any recent provoking factors such as  trauma, surgery, or a long plane trip. The sudden death of this  patient's paternal uncle at a young age should raise a red flag that he  may have an inherited hypercoagulable condition. The most common cause  of inherited thrombophilia (accounting for approximately 50% of cases) is Factor V Leiden, the presence of which results in a resistance to the antithrombotic effects of protein C. Confirming a diagnosis of inherited thrombophilia is extremely important because  these patients have an increased risk of developing DVTs, pulmonary  emboli, and blood clots in other locations. As a result, they may need  to be placed on lifelong anticoagulation.</p>
<p>A prothrombin gene mutation (G20210A) is a common  cause of inherited thrombophilia, but it does not necessarily result in a higher level of the protein.</p>
<p>Protein S helps to block coagulation and deficiency of it can lead to  thrombophilia. Inherited protein S deficiency is rare compared to the  frequency of Factor V Leiden. Antithrombin III deficiency is a relatively rare cause of inherited thrombophilia. Abnormalities in the quantity or functioning of fibrinogen can lead to either  bleeding or clotting disorders. However, Factor V Leiden is a more  common cause of inherited thrombophilia.</p>
<h2 id="fat-emboli" tabindex="-1">Fat Emboli</h2>
<p>Early immobilization and operative fixation of fractures reduces the  chances of fat embolism. Supportive care is the mainstay of therapy for clinically apparent fat embolism.</p>
<p>There is no evidence that prophylactic heparin reduces the risk of fat  embolism. The use of corticosteroid prophylaxis is controversial,  largely because it is difficult to definitively prove its efficacy in a  condition with a low incidence, unclear risk factors, low mortality, and a good outcome with conservative management.</p>
<h2 id="dvt" tabindex="-1">DVT</h2>
<!-- DVT evaluation negative US, high D Dimer -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220530142511.png" alt="">
Although not enough clinical information is provided to assess this patient's modified Wells score, her recent long air flight, new-onset unilateral leg edema/pain, and positive Homan sign (pain in the calf on dorsiflexion of the foot) suggest a high pretest probability for <strong>deep venous thrombosis</strong> (DVT). Negative US with positive D Dimer: repeat US in days.</p>
<p>Patients with suspected DVT are evaluated based on pretest probability as follows:</p>
<ul>
<li>Low probability – Obtain moderate- or high-sensitivity d-dimer level.  A normal d-dimer rules out DVT (d-dimer has a sensitivity of up to 96% but specificity is low); an elevated d-dimer necessitates further evaluation with compression ultrasonography (CUS).</li>
<li><strong>High probability</strong> – Proceed directly to <strong>CUS</strong>, which has a diagnostic sensitivity of &gt;97% for DVT.  As <strong>false negatives</strong> can occasionally (&lt;3%) occur, patients with a high pretest probability of DVT who have negative CUS testing, continue to be symptomatic, have no clear alternate diagnosis, and have an elevated d-dimer should have <strong>repeat CUS within days</strong>
Patients with moderate pretest probability can be initially evaluated with either high sensitivity d-dimer (normal rules out; elevated requires CUS) or CUS.</li>
</ul>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#fat-emboli">Fat Emboli</a></li><li><a href="#dvt">DVT</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Cardiology/" class="peer">Cardiology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="cardiology" tabindex="-1">Cardiology</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="anatomy" tabindex="-1">Anatomy</h2>
<ul>
<li>Epidemiology and Risk Factors</li>
<li><a href="/wiki/notes/Diagnostic%20Testing%20in%20Cardiology/">Diagnostic Testing in Cardiology</a></li>
<li><a href="/wiki/notes/Coronary%20Artery%20Disease/">Coronary Artery Disease</a></li>
<li><a href="/wiki/notes/Heart%20Failure/">Heart Failure</a></li>
<li><a href="/wiki/notes/Arrhythmias/">Arrhythmias</a></li>
<li><a href="/wiki/notes/Valvular%20Heart%20Disease/">Valvular Heart Disease</a></li>
<li><a href="/wiki/notes/Myocardial%20Disease/">Myocardial Disease</a></li>
<li><a href="/wiki/notes/Pericardial%20Disease/">Pericardial Disease</a></li>
<li><a href="/wiki/notes/Adult%20Congenital%20Heart%20Disease/">Adult Congenital Heart Disease</a></li>
<li><a href="/wiki/notes/Diseases%20of%20the%20Aorta/">Diseases of the Aorta</a></li>
<li><a href="/wiki/notes/Peripheral%20Artery%20Disease/">Peripheral Artery Disease</a></li>
<li><a href="/wiki/notes/Cardiovascular%20Disease%20in%20Cancer%20Survivors/">Cardiovascular Disease in Cancer Survivors</a></li>
<li><a href="/wiki/notes/Pregnancy%20and%20Cardiovascular%20Disease/">Pregnancy and Cardiovascular Disease</a></li>
</ul>
<h1 id="" tabindex="-1"></h1>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hemeonc/" class="peer">Hemeonc</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="hemeonc" tabindex="-1">Hemeonc</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/management%20of%20bone%20metastasis/">management of bone metastasis</a></li>
<li><a href="/wiki/notes/Hematopoietic%20Stem%20Cells%20and%20Their%20Disorders/">Hematopoietic Stem Cells and Their Disorders</a></li>
<li><a href="/wiki/notes/Multiple%20Myeloma%20and%20Related%20Disorders/">Multiple Myeloma and Related Disorders</a></li>
<li><a href="/wiki/notes/Erythrocyte%20Disorders/">Erythrocyte Disorders</a></li>
<li><a href="/wiki/notes/Iron%20Overload%20Syndromes/">Iron Overload Syndromes</a></li>
<li><a href="/wiki/notes/Platelet%20Disorders/">Platelet Disorders</a></li>
<li><a href="/wiki/notes/MKSAP%20Bleeding%20Disorders/">MKSAP Bleeding Disorders</a></li>
<li><a href="/wiki/notes/MKSAP%20Transfusion%20Medicine/">MKSAP Transfusion Medicine</a></li>
<li><a href="/wiki/notes/Thrombotic%20Disorders/">Thrombotic Disorders</a></li>
<li><a href="/wiki/notes/Hematologic%20Issues%20in%20Pregnancy/">Hematologic Issues in Pregnancy</a></li>
<li><a href="/wiki/notes/Issues%20in%20Oncology/">Issues in Oncology</a></li>
<li><a href="/wiki/notes/Breast%20Cancer/">Breast Cancer</a></li>
<li><a href="/wiki/notes/Ovarian%20Cancer/">Ovarian Cancer</a></li>
<li>[[M</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
